Platinum Investment Management LTD Coherus Bio Sciences, Inc. Transaction History

Platinum Investment Management LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $347,063 - $671,377	-48,405 Reduced 8.09%	549,899 $5.29 Million
Q2 2022 Aug 11, 2022	BUY	$5.86 - $13.23 $370,328 - $836,083	63,196 Added 11.81%	598,304 $4.33 Million
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $638,755 - $767,233	-40,402 Reduced 7.02%	535,108 $8.54 Million
Q2 2021 Aug 11, 2021	BUY	$12.95 - $15.41 $1.35 Million - $1.61 Million	104,225 Added 22.12%	575,510 $7.96 Million
Q1 2021 May 13, 2021	BUY	$14.42 - $21.39 $4.75 Million - $7.04 Million	329,251 Added 231.81%	471,285 $6.89 Million
Q2 2020 Aug 06, 2020	SELL	$14.43 - $19.16 $490,966 - $651,899	-34,024 Reduced 19.33%	142,034 $2.54 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $184,327 - $355,861	15,795 Added 9.86%	176,058 $2.86 Million
Q4 2019 Feb 13, 2020	SELL	$16.33 - $21.37 $130,215 - $170,404	-7,974 Reduced 4.74%	160,263 $2.89 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $291,619 - $491,968	-22,261 Reduced 11.69%	168,237 $3.72 Million
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $206,030 - $381,083	-24,586 Reduced 11.43%	190,498 $2.6 Million
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $675,426 - $1.27 Million	78,084 Added 57.0%	215,084 $1.95 Million
Q1 2018 May 15, 2018	BUY	$9.1 - $13.7 $252,980 - $380,860	27,800 Added 25.46%	137,000 $1.51 Million
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $1.21 Million - $1.58 Million	109,200	109,200 $1.46 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.